Please be patient! It may take up to ONE minute to load all the Engines.
Problems? Please contact our support.
Gestational trophoblastic disease
Gestational trophoblastic disease, or choriocarcinoma, is an aggressive, malignant, often metastatic (spreading to other organs) cancer in the uterus that begins following a pregnancy, a miscarriage, or an abortion.
Choriocarciona is among the most sensitive cancers to chemotherapy. As such, even when choriocarcinoma is metastatic, the cure rate is between 90 and 95%.
Causes, incidence, and risk factors
Hydatiform mole is a condition which develops when a pregnancy has many complications. Conception takes place, but placental tissue grows very fast, rather than supporting the growth of a fetus.
The result is a tumor, rather than a baby. This is known as a molar pregnancy. There are only about 3,000 molar preganancies per year in the United States.
Choriocarcinoma is a similar type of growth. In approximately one-half of cases of choriocarcinoma, the preceding factor is hydatidiform mole. However, only 5 to 10% of molar pregnancies are associated with later choriocarcinoma. Therefore, choriocarcinoma remains an uncommon, yet almost always curable, cancer that can be associated with pregnancy.
Nearly one-fourth of choriocarcinomas follow a term pregnancy, from which a normal child has been delivered. The remainder follow an abortion (spontaneous, elective, or therapeutic), ectopic pregnancy , or genital tumor .
A possible symptom is continued vaginal bleeding in a woman with a recent history of hydatidiform mole , abortion , or term pregnancy.
Additional symptoms that may be associated with this disease include:
Signs and testsA pelvic examination may reveal continued uterine enlargement or a tumor . These conditions may be felt within the genito-urinary tract.
After an initial diagnosis, a careful history and examination are done to rule out metastasis (spread to other organs). Chemotherapy is the treatment of choice.
A hysterectomy is rarely required, due to choriocarcinoma's extreme sensitivity to chemotherapy. More than 90% of women with malignant, nonmetastatic disease are able to maintain reproductive capabilities.
Support GroupsThe stress of illness can often be helped by joining a support group where members share common experiences and problems. See cancer - support group .
Nearly all women with malignant, nonmetastatic disease are cured, with more than 90% preserving reproductive function.
Some women with malignant, metastatic disease may have a poor prognosis if they meet one of the following conditions:
Almost all women who receive a good prognosis with malignant, metastatic disease that does not meet one of these conditions experience remission.
Choriocarcinoma may recur, usually within several months but possibly as late as 3 years after treatment ends. Complications associated with chemotherapy or surgery can also occur.
If a hysterectomy is performed, infertility will result. Menopause will begin if the ovaries are also removed.
Calling your health care providerCall for an appointment with your health care provider if symptoms arise within 1 year after hydatidiform mole , abortion (including miscarriage), or term pregnancy.
PreventionAlthough careful monitoring after the removal of hydatidiform mole or termination of pregnancy may not prevent the development of choriocarcinoma, it is essential in early identification of the condition, which improves outcome.
Update Date: 8/6/2002Kevin Knopf, M.D., M.P.H., Hematologist/Oncologist and Director of Clinical Research, Annapolis Oncology/Hematology Center, Annapolis, MD. Review provided by VeriMed Healthcare Network.
Last updated: Tue, 06 Jan 2009 00:20:03 GMT